News New drugs boost Eli Lilly, ahead of animal health IPO Eli Lilly closed the second quarter with substantial revenue increase thanks to a strong performance from a group of recently-approved drugs.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
